Results 121 to 130 of about 29,583 (248)
Background Ductal Carcinoma In Situ (DCIS) can progress to invasive breast cancer, but most DCIS lesions never will. Therefore, four clinical trials (COMET, LORIS, LORETTA, AND LORD) test whether active surveillance for women with low-risk Ductal ...
Sena Alaeikhanehshir +11 more
doaj +1 more source
Objectives To assess the risk of fractures among patients with bladder cancer who underwent radical cystectomy (RC) with urinary diversion (UD), compared with matched referents from the general population. Patients/Subjects and Methods We identified 2908 patients who underwent RC between 2011 and 2019, and 13 669 matched referents in a nationwide ...
Mieke Van Hemelrijck +10 more
wiley +1 more source
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ
Background Ductal carcinoma in-situ (DCIS) is a pre-invasive form of invasive breast cancer (IBC). Due to improved breast cancer screening, it now accounts for ~ 25% of all breast cancers. While the treatment success rates are over 90%, this comes at the
Marija Debeljak +19 more
doaj +1 more source
ABSTRACT Most research in Death Studies focuses on adult perspectives. Even when children are the intended focus, this research often remains adult‐centred due to the dominance of developmental psychology. A key concept underpinning this approach is the ‘mature death concept’ (MDC), a normative framework that assumes children's understanding of death ...
Renske Visser, Karin Murris
wiley +1 more source
Digital analysis of spatial expression of stromal fibroblast activation protein alpha (FAP) in DCIS
Digital analysis of FAP expression in DCIS revealed a higher FAP level around DCIS with nearby invasion, comparable to invasive carcinoma. High FAP correlated with nuclear grade, papillary DCIS and HER2 subtype, showing prognostic potential. Introduction The presence of non‐progressing ductal carcinoma in situ (DCIS) cases has raised concerns of ...
Ka Long Leung +10 more
wiley +1 more source
Cooperative Genomic Events Driving Mutant TP53-Driven DCIS Progression
Ductal carcinoma in situ (DCIS) is a mammary lesion characterized by abnormal epithelial cells occurring in mammary ducts while still being confined to the luminal space.
Morrissey, Rhiannon L
core +1 more source
Curing Capacity of Band‐Bonding Resinous Adhesives Under 3D‐Printed Molar Bands
ABSTRACT Aim To evaluate the curing efficiency of three resin composite adhesives applied beneath 3D‐printed molar bands, by determining their degree of conversion (DC%) at different depths. Materials and Methods Fifteen 3D‐printed metallic band specimens were divided into three groups and bonded with Band Lock Blue (BLB), Optiband Ultra Blue (OBU), or
Sofia Sideri +5 more
wiley +1 more source
Background/Objectives: Thirty to fifty percent of ductal carcinoma in situ (DCIS) cases are high-grade and at risk of progressing to invasive carcinoma. The most important treatment-related risk factor for recurrence is the presence of residual DCIS. The
Hülya Çetin Tunçez +5 more
doaj +1 more source
Does the Oncotype DCIS score impact treatment decisions?
91 Background: The Oncotype Dx DCIS Score has been developed and validated for risk recurrence in ductal carcinoma in situ. It is a 12 gene assay performed on an individual patient’s tumor.
Paul R. Gliedman +6 more
core +1 more source
Is the World Getting Smaller? Network‐Driven Heterogeneity in Gravity‐Model Elasticities
ABSTRACT Gravity models constitute the workhorse of empirical international trade research, yet the temporal stability of their core parameters—distance and GDP elasticities—remains underexplored, particularly in relation to the evolving structure of trade networks.
Zsolt T. Kosztyán +2 more
wiley +1 more source

